Fri, Oct 18, 2024
Torrent Pharmaceuticals on Friday said it has received a demand notice of Rs 6.32 lakh from the National Pharmaceutical Pricing Authority (NPPA). The company has received the notice from NPPA under paragraph 15 of Drug Price Control Order 2013, imposing a penalty of Rs 6,32,689.
More >
Fri, Sep 20, 2024
The drug maker will respond to the USFDA within the prescribed timeframe and will work in close collaboration with it to address the observation at the earliest possible time, the company said.
Wed, Jun 05, 2024
Vonoprozan is a novel potassium-competitive acid blocker (P-CAB), used for the treatment of acid related disorders gastroesophageal reflux disease.
Wed, Oct 25, 2023
Operating EBITDA during the period came in at Rs 825 crore, up 22 per cent YoY. In the Q2 period of the previous fiscal, operation profitability was at Rs 679 crore.
Wed, Sep 28, 2022
Torrent Pharmaceuticals' share price slipped 5.5% to Rs 1449.25 per share on the BSE. The slump in the stock of mid-cap pharma company was mainly attributed to the expensive deal with Curatio Healthcare
Tue, Sep 27, 2022
Torrent Pharmaceuticals on Tuesday said it will acquire Curatio Healthcare for Rs 2,000 crore to strengthen its presence in the dermatology segment.
Thu, Jan 27, 2022
Shares of Torrent Pharma were locked in lower circuit as they declined 13 per cent to Rs 2704.80 per share in Thursday's intraday trade on the BSE.
Wed, May 19, 2021
A day after the release of its quarter-four results, Torrent Pharma surges around six per cent to Rs 2891 per share on the BSE intraday on Wednesday. Meanwhile, the brokerage firms had shown a mixed reaction towards the drug makers' earnings of the last quarter of FY21.
Tue, Feb 09, 2021
Torrent Pharmaceuticals reported healthy performance for Q3 FY21, led by a slightly better than expected operating performance. Revenues for the quarter stood at Rs 1995 cr, up by a meager 1.5% yoy and were in line with the estimates. The operating margins for the quarter stood at 30.4%, up by 296 bps yoy, driven by savings in the other expenses.
Wed, Jan 13, 2021
Torrent Pharmaceuticals to Cadila Healthcare, Natco Pharma to IPCA Labs results preview: Q3 FY21 is expected to have been a good quarter for Indian pharma companies. Some of the benefits from H1 FY21 are expected to have boosted growth. Sales of the companies we cover are expected to have risen 9.2% to Rs 157 bn, driven by a strong rebound in India sales, greater demand for APIs and stable pricing in the US. EBITDA margins may be high due to less promotional and travelling expenses associated with the domestic business.
Thu, Oct 10, 2019
Indiabulls Housing Finance, Jet Airways, Torrent Pharmaceuticals, Bharti Airtel and other telecom stocks will remain newsmakers of the day.
Tue, Aug 13, 2019
Certain stocks came in news after the markets were closed on Friday and can have an impact on the indices after it opens today.
Thu, Jul 18, 2019
IRCON/SAIL/RVNL, NMDC, Torrent Pharmaceuticals and Allahabad Bank are the stocks that are expected to remain in news today.
Fri, Dec 21, 2018
Losartan is used to treat hypertension, hypertensive patients with Left Ventricular Hypertrophy and for the treatment of nephropathy in Type 2 diabetic patients.
Mon, Aug 20, 2018
The reason for the recall had been stated as an impurity, N-nitrosodimethylamine (NDMA), detected in the active pharmaceutical ingredients (API). NDMA is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen by International Agency for Research on Cancer (IARC).
Mon, Jun 05, 2017
It has been a long and dreary quarter for pharmaceutical companies in Q4 wherein most posted a decline in net profit and things are not looking too good for the Indian pharma companies in the first half of FY18 as well.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
